Operating income decreased 9.4%
Operating income changed -9.4% from the comparable as-filed period.
-$1.9M→-$2.1M2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →CSAI financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Revenue increased 13.1%
Revenue changed +13.1% from the comparable as-filed period.
$1.1M→$1.2M2 prior comparisons
Operating cash flow decreased 6.8%
Operating cash flow changed -6.8% from the comparable as-filed period.
-$1.8M→-$1.9M3 prior comparisons
R&D / revenue moved 1146 bp higher
R&D / revenue changed +1146 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
34.77%→46.23%2 prior comparisons
Operating cash-flow margin moved 933 bp higher
Operating cash-flow margin changed +933 basis points from the comparable as-filed period.
-167.16%→-157.83%2 prior comparisons
Free-cash-flow margin moved 2107 bp higher
Free-cash-flow margin changed +2107 basis points from the comparable as-filed period.
-178.17%→-157.10%2 prior comparisons
Working capital / assets moved 1092 bp lower
Working capital / assets changed -1092 basis points from the comparable as-filed period.
86.76%→75.83%3 prior comparisons
Current ratio decreased 44.0%
Current ratio changed -44.0% from the comparable as-filed period.
8.85→4.963 prior comparisons
Receivables / revenue moved 3673 bp higher
Receivables / revenue changed +3673 basis points from the comparable as-filed period.
45.50%→82.24%2 prior comparisons
Current liabilities increased 14.0%
Current liabilities changed +14.0% from the comparable as-filed period.
$1.0M→$1.1M3 prior comparisons
Capital expenditure changed across a sign change
Capital expenditure changed -107.5% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change. This reverses 2 consecutive comparable moves in the opposite direction.
$120,000→-$9,0003 prior comparisons
Cost of revenue decreased 9.2%
Cost of revenue changed -9.2% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$686,000→$623,0002 prior comparisons
Free-cash-flow proxy increased 0.3%
Free-cash-flow proxy changed +0.3% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
-$1.9M→-$1.9M3 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.